Hepatology (Baltimore, Md.)
Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.
Evidence based consensus guidelines for diagnosis and management of Protoporphyria-Related liver dysfunction in erythropoietic protoporphyria and X-Linked protoporphyria.
Reply: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection?
Time to embrace PROMIS-29 as the standard health-related quality of life instrument for patients with cirrhosis.
AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies.
Reply: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB.
Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
The impact of right atrial pressure on outcomes in patients undergoing TIPS, An ALTA group study.
